Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

By Yamamoto Taketsugu   Oshima Takashi   Yoshihara Kazue   Nishi Teppei   Arai Hiromasa   Inui Kenji   Kaneko Takeshi   Nozawa Akinori   Adachi Hiroyuki   Rino Yasushi   Masuda Munetaka   Imada Toshio  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-05 ,pp. : 797-802

Spandidos Publications

Access to resources Recommend Favorite

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas

By Wu Pei-Fang   Huang Wen-Chang   Yang James   Lu Yen-Shen   Shih Jin-Yuan   Wu Shang-Gin   Lin Ching-Hung   Cheng Ann-Lii  

Journal of Neuro-Oncology, Vol. 115, Iss. 1, 2013-10 ,pp. : 61-70

Springer Publishing Company

Access to resources Recommend Favorite

Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma

By Hartog Hermien  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 725-736

Springer Publishing Company

Access to resources Recommend Favorite

Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

By Ekman Simon   Fröödin Jan-Erik   Harmenberg Johan   Bergman Antonina   Hedlund ÅÅsa   Dahg Pia   Alvfors Carina   Stååhl Birgitta   Bergströöm Stefan   Bergqvist Michael  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite